SBIR/STTR Research Award

Technologies for Identifying Short-lived Proteins

Award identifier 0e78bb32bbb9f8a2a054f0ab57cc9279345ee61e3b8639bf91accbb25f8dcaf3Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$140,000

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Panomics, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Most regulatory proteins turn over rapidly. We will develop an innovative technology to identify labile proteins, using libraries of proteins fused to green fluorescent protein (GFP) to monitor protein degradation. We will make GFP-cDNA expression libraries by fusing cDNA downstream from the C terminus of GFP. GFP can be detected in real time in living cells without disrupting the cells. We will identify cells expressing short-lived proteins by selecting for appropriate time- dependent changes in cellular fluorescence. Cells with the desired characteristics will be isolated and subjected to gene recovery and sequence analysis. The transfected cDNAs in those cells will be recovered, cloned and sequenced and, after analysis and annotation, established as a database. We anticipate that the transcripts from most of the genes we expect to identify will be highly regulated. A microarray of these genes provides an efficient way to examine the changes of their transcripts under different physiological conditions. We will commercialize the gene clones, expression cell lines and bioinformatic database as well as related reagents. PROPOSED COMMERCIAL APPLICATIONS: Labile proteins usually have important regulatory roles in cells. We will develop a general method to reveal labile proteins and will market the information and products thus produced. In addition to constitutively labile proteins, we will identify proteins whose degradation is induced by specific conditions in specific cells. The possible combinations of proteins, cells and inciting agents are effectively limitless. These products will therefore enjoy a durable and sizeable market.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.